Global Oxcarbazepine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 218114
  • calendar_today Published On: Nov, 2019
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare

Scope of the Report:

The worldwide market for Oxcarbazepine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.

This report focuses on the Oxcarbazepine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Novartis (Trileptal)

Stada Group

Ranbaxy Pharmaceuticals

Supernus Pharmaceuticals (Oxtellar XR)

Mylan

Sun Pharm

ANI Pharmaceuticals

Taro Pharmaceuticals

Jubilant Generics

Glenmark Pharmaceuticals

Nexgen pharma

Jamp Pharma

Teva Pharmaceutical

Orion Corporation

Amneal Pharmaceuticals

Apotex

Roxane Laboratories

Neuraxpharm

Hikma Pharmaceuticals

Nobelpharma

Sihuan Pharm

Humanwell Healthcare

Huikang Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Tablets (150mg, 300mg, 600mg)

Oral Suspension

Market Segment by Applications, can be divided into

Pediatric Use (Aged 2-4 years, 4-16 years)

Adult Use

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Oxcarbazepine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Oxcarbazepine, with price, sales, revenue and global market share of Oxcarbazepine in 2017 and 2018.

Chapter 3, the Oxcarbazepine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oxcarbazepine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Oxcarbazepine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Oxcarbazepine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Oxcarbazepine Introduction

1.2 Market Analysis by Type

1.2.1 Tablets (150mg, 300mg, 600mg)

1.2.2 Oral Suspension

1.3 Market Analysis by Applications

1.3.1 Pediatric Use (Aged 2-4 years, 4-16 years)

1.3.2 Adult Use

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novartis (Trileptal)

2.1.1 Business Overview

2.1.2 Oxcarbazepine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Stada Group

2.2.1 Business Overview

2.2.2 Oxcarbazepine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Stada Group Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Ranbaxy Pharmaceuticals

2.3.1 Business Overview

2.3.2 Oxcarbazepine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Supernus Pharmaceuticals (Oxtellar XR)

2.4.1 Business Overview

2.4.2 Oxcarbazepine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Mylan

2.5.1 Business Overview

2.5.2 Oxcarbazepine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mylan Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Sun Pharm

2.6.1 Business Overview

2.6.2 Oxcarbazepine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sun Pharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 ANI Pharmaceuticals

2.7.1 Business Overview

2.7.2 Oxcarbazepine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 ANI Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Taro Pharmaceuticals

2.8.1 Business Overview

2.8.2 Oxcarbazepine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Taro Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Jubilant Generics

2.9.1 Business Overview

2.9.2 Oxcarbazepine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Jubilant Generics Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Glenmark Pharmaceuticals

2.10.1 Business Overview

2.10.2 Oxcarbazepine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Nexgen pharma

2.11.1 Business Overview

2.11.2 Oxcarbazepine Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Nexgen pharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Jamp Pharma

2.12.1 Business Overview

2.12.2 Oxcarbazepine Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Jamp Pharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.13 Teva Pharmaceutical

2.13.1 Business Overview

2.13.2 Oxcarbazepine Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Teva Pharmaceutical Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.14 Orion Corporation

2.14.1 Business Overview

2.14.2 Oxcarbazepine Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Orion Corporation Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.15 Amneal Pharmaceuticals

2.15.1 Business Overview

2.15.2 Oxcarbazepine Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.16 Apotex

2.16.1 Business Overview

2.16.2 Oxcarbazepine Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Apotex Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.17 Roxane Laboratories

2.17.1 Business Overview

2.17.2 Oxcarbazepine Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Roxane Laboratories Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.18 Neuraxpharm

2.18.1 Business Overview

2.18.2 Oxcarbazepine Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Neuraxpharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.19 Hikma Pharmaceuticals

2.19.1 Business Overview

2.19.2 Oxcarbazepine Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.20 Nobelpharma

2.20.1 Business Overview

2.20.2 Oxcarbazepine Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Nobelpharma Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.21 Sihuan Pharm

2.21.1 Business Overview

2.21.2 Oxcarbazepine Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Sihuan Pharm Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.22 Humanwell Healthcare

2.22.1 Business Overview

2.22.2 Oxcarbazepine Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Humanwell Healthcare Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.23 Huikang Pharmaceutical

2.23.1 Business Overview

2.23.2 Oxcarbazepine Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Huikang Pharmaceutical Oxcarbazepine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Oxcarbazepine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Oxcarbazepine Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Oxcarbazepine Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Oxcarbazepine Manufacturer Market Share in 2018

3.3.2 Top 6 Oxcarbazepine Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Oxcarbazepine Market Analysis by Regions

4.1 Global Oxcarbazepine Sales, Revenue and Market Share by Regions

4.1.1 Global Oxcarbazepine Sales and Market Share by Regions (2014-2019)

4.1.2 Global Oxcarbazepine Revenue and Market Share by Regions (2014-2019)

4.2 North America Oxcarbazepine Sales and Growth Rate (2014-2019)

4.3 Europe Oxcarbazepine Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Oxcarbazepine Sales and Growth Rate (2014-2019)

4.5 South America Oxcarbazepine Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Oxcarbazepine Sales and Growth Rate (2014-2019)

5 North America Oxcarbazepine by Country

5.1 North America Oxcarbazepine Sales, Revenue and Market Share by Country

5.1.1 North America Oxcarbazepine Sales and Market Share by Country (2014-2019)

5.1.2 North America Oxcarbazepine Revenue and Market Share by Country (2014-2019)

5.2 United States Oxcarbazepine Sales and Growth Rate (2014-2019)

5.3 Canada Oxcarbazepine Sales and Growth Rate (2014-2019)

5.4 Mexico Oxcarbazepine Sales and Growth Rate (2014-2019)

6 Europe Oxcarbazepine by Country

6.1 Europe Oxcarbazepine Sales, Revenue and Market Share by Country

6.1.1 Europe Oxcarbazepine Sales and Market Share by Country (2014-2019)

6.1.2 Europe Oxcarbazepine Revenue and Market Share by Country (2014-2019)

6.2 Germany Oxcarbazepine Sales and Growth Rate (2014-2019)

6.3 UK Oxcarbazepine Sales and Growth Rate (2014-2019)

6.4 France Oxcarbazepine Sales and Growth Rate (2014-2019)

6.5 Russia Oxcarbazepine Sales and Growth Rate (2014-2019)

6.6 Italy Oxcarbazepine Sales and Growth Rate (2014-2019)

7 Asia-Pacific Oxcarbazepine by Country

7.1 Asia-Pacific Oxcarbazepine Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Oxcarbazepine Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Oxcarbazepine Revenue and Market Share by Country (2014-2019)

7.2 China Oxcarbazepine Sales and Growth Rate (2014-2019)

7.3 Japan Oxcarbazepine Sales and Growth Rate (2014-2019)

7.4 Korea Oxcarbazepine Sales and Growth Rate (2014-2019)

7.5 India Oxcarbazepine Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Oxcarbazepine Sales and Growth Rate (2014-2019)

8 South America Oxcarbazepine by Country

8.1 South America Oxcarbazepine Sales, Revenue and Market Share by Country

8.1.1 South America Oxcarbazepine Sales and Market Share by Country (2014-2019)

8.1.2 South America Oxcarbazepine Revenue and Market Share by Country (2014-2019)

8.2 Brazil Oxcarbazepine Sales and Growth Rate (2014-2019)

8.3 Argentina Oxcarbazepine Sales and Growth Rate (2014-2019)

8.4 Colombia Oxcarbazepine Sales and Growth Rate (2014-2019)

9 Middle East and Africa Oxcarbazepine by Countries

9.1 Middle East and Africa Oxcarbazepine Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Oxcarbazepine Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Oxcarbazepine Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Oxcarbazepine Sales and Growth Rate (2014-2019)

9.3 Turkey Oxcarbazepine Sales and Growth Rate (2014-2019)

9.4 Egypt Oxcarbazepine Sales and Growth Rate (2014-2019)

9.5 Nigeria Oxcarbazepine Sales and Growth Rate (2014-2019)

9.6 South Africa Oxcarbazepine Sales and Growth Rate (2014-2019)

10 Global Oxcarbazepine Market Segment by Type

10.1 Global Oxcarbazepine Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Oxcarbazepine Sales and Market Share by Type (2014-2019)

10.1.2 Global Oxcarbazepine Revenue and Market Share by Type (2014-2019)

10.2 Tablets (150mg, 300mg, 600mg) Sales Growth and Price

10.2.1 Global Tablets (150mg, 300mg, 600mg) Sales Growth (2014-2019)

10.2.2 Global Tablets (150mg, 300mg, 600mg) Price (2014-2019)

10.3 Oral Suspension Sales Growth and Price

10.3.1 Global Oral Suspension Sales Growth (2014-2019)

10.3.2 Global Oral Suspension Price (2014-2019)

11 Global Oxcarbazepine Market Segment by Application

11.1 Global Oxcarbazepine Sales Market Share by Application (2014-2019)

11.2 Pediatric Use (Aged 2-4 years, 4-16 years) Sales Growth (2014-2019)

11.3 Adult Use Sales Growth (2014-2019)

12 Oxcarbazepine Market Forecast (2019-2024)

12.1 Global Oxcarbazepine Sales, Revenue and Growth Rate (2019-2024)

12.2 Oxcarbazepine Market Forecast by Regions (2019-2024)

12.2.1 North America Oxcarbazepine Market Forecast (2019-2024)

12.2.2 Europe Oxcarbazepine Market Forecast (2019-2024)

12.2.3 Asia-Pacific Oxcarbazepine Market Forecast (2019-2024)

12.2.4 South America Oxcarbazepine Market Forecast (2019-2024)

12.2.5 Middle East and Africa Oxcarbazepine Market Forecast (2019-2024)

12.3 Oxcarbazepine Market Forecast by Type (2019-2024)

12.3.1 Global Oxcarbazepine Sales Forecast by Type (2019-2024)

12.3.2 Global Oxcarbazepine Market Share Forecast by Type (2019-2024)

12.4 Oxcarbazepine Market Forecast by Application (2019-2024)

12.4.1 Global Oxcarbazepine Sales Forecast by Application (2019-2024)

12.4.2 Global Oxcarbazepine Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Oxcarbazepine Picture

Table Product Specifications of Oxcarbazepine

Figure Global Sales Market Share of Oxcarbazepine by Types in 2018

Table Oxcarbazepi

Please fill the form below, to recieve the report sample


+1